New Online

This post hoc analysis of a randomized clinical trial investigates if patients 80 years and older with atrial fibrillation benefit from lower-dose anticoagulants even in the absence of prespecified dose-reduction criteria.

This secondary analysis of the ADAPTABLE (Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-Term Effectiveness) randomized clinical trial investigates if there are sex-specific differences in the safety and effectiveness of 2 aspirin doses for the secondary prevention of atherosclerotic cardiovascular disease (CVD).

This study discusses women’s representation in interventional cardiology.

This case-control study investigates the ability of a large-scale proteomics panel from first-trimester blood samples to predict the development of hypertensive disorders of pregnancy.

This randomized clinical trial evaluates the safety and efficacy of lerodalcibep vs placebo in reduction of low-density lipoprotein cholesterol in patients with or at risk of cardiovascular disease.

This case report describes a diagnosis of extracardiac mural thrombus and pulmonary emboli resulting from a left atrial appendage device in a patient with atrial fibrillation.